Advertisement
Screener

Vaccinex, Inc. (VCNX) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

Vaccinex, Inc. Comprehensive Income

Vaccinex, Inc. (VCNX) reported Comprehensive Income of -$18.63 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.

Financial Statements › Income Statement

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-04-15

  • Vaccinex, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$3.37M.
  • Vaccinex, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$5.73M.
  • Vaccinex, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was -$5.63M.
  • Vaccinex, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-03-31 was -$3.90M.
  • Vaccinex, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$18.63M.
  • Vaccinex, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$20.25M.
  • Vaccinex, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$19.82M.
  • Vaccinex, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$22.38M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2024-12-31-$3.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-$9.11M
derived: sum of 2 quarters · filed 2025-04-15
-$14.74M
derived: sum of 3 quarters · filed 2025-04-15
-$18.63M
10-K · filed 2025-04-15
2024-09-30-$5.73M
10-Q · filed 2024-11-14
-$11.36M
derived: sum of 2 quarters · filed 2024-11-14
-$15.26M
10-Q · filed 2024-11-14
-$18.58M
derived: sum of 4 quarters · filed 2025-04-15
2024-06-30-$5.63M
10-Q · filed 2024-08-14
-$9.53M
10-Q · filed 2024-08-14
-$12.85M
derived: sum of 3 quarters · filed 2025-04-15
-$17.76M
derived: sum of 4 quarters · filed 2025-04-15
2024-03-31-$3.90M
10-Q · filed 2024-05-15
-$7.21M
derived: sum of 2 quarters · filed 2025-04-15
-$12.13M
derived: sum of 3 quarters · filed 2025-04-15
-$19.19M
derived: sum of 4 quarters · filed 2025-04-15
2023-12-31-$3.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-$8.23M
derived: sum of 2 quarters · filed 2025-04-15
-$15.29M
derived: sum of 3 quarters · filed 2025-04-15
-$20.25M
10-K · filed 2025-04-15
2023-09-30-$4.91M
10-Q · filed 2024-11-14
-$11.97M
derived: sum of 2 quarters · filed 2024-11-14
-$16.93M
10-Q · filed 2024-11-14
-$22.01M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$7.06M
10-Q · filed 2024-08-14
-$12.02M
10-Q · filed 2024-08-14
-$17.10M
derived: sum of 3 quarters · filed 2024-08-14
-$21.86M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$4.96M
10-Q · filed 2024-05-15
-$10.04M
derived: sum of 2 quarters · filed 2024-05-15
-$14.80M
derived: sum of 3 quarters · filed 2024-05-15
-$20.18M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$5.08M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-04-25
-$9.84M
derived: sum of 2 quarters · filed 2024-04-25
-$15.22M
derived: sum of 3 quarters · filed 2024-04-25
-$19.82M
10-K/A · filed 2024-04-25
2022-09-30-$4.76M
10-Q · filed 2023-11-13
-$10.14M
derived: sum of 2 quarters · filed 2023-11-13
-$14.74M
10-Q · filed 2023-11-13
-$19.37M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$5.38M
10-Q · filed 2023-08-14
-$9.98M
10-Q · filed 2023-08-14
-$14.61M
derived: sum of 3 quarters · filed 2023-08-14
-$19.82M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$4.59M
10-Q · filed 2023-05-15
-$9.23M
derived: sum of 2 quarters · filed 2023-05-15
-$14.43M
derived: sum of 3 quarters · filed 2023-05-15
-$20.40M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$4.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$9.84M
derived: sum of 2 quarters · filed 2023-03-31
-$15.81M
derived: sum of 3 quarters · filed 2023-03-31
-$22.38M
10-K · filed 2023-03-31
2021-09-30-$5.21M
10-Q · filed 2022-11-14
-$11.18M
derived: sum of 2 quarters · filed 2022-11-14
-$17.75M
10-Q · filed 2022-11-14
-$24.19M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$5.97M
10-Q · filed 2022-08-15
-$12.54M
10-Q · filed 2022-08-15
-$18.99M
derived: sum of 3 quarters · filed 2022-08-15
-$27.74M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$6.57M
10-Q · filed 2022-05-16
-$13.02M
derived: sum of 2 quarters · filed 2022-05-16
-$21.77M
derived: sum of 3 quarters · filed 2022-05-16
-$28.27M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$6.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$15.20M
derived: sum of 2 quarters · filed 2022-03-31
-$21.70M
derived: sum of 3 quarters · filed 2022-03-31
-$28.85M
10-K · filed 2022-03-31
2020-09-30-$8.75M
10-Q · filed 2021-11-08
-$15.26M
derived: sum of 2 quarters · filed 2021-11-08
-$22.41M
10-Q · filed 2021-11-08
-$28.73M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30-$6.50M
10-Q · filed 2021-08-16
-$13.65M
10-Q · filed 2021-08-16
-$19.98M
derived: sum of 3 quarters · filed 2021-08-16
-$27.62M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$7.15M
10-Q · filed 2021-05-17
-$13.47M
derived: sum of 2 quarters · filed 2021-05-17
-$21.12M
derived: sum of 3 quarters · filed 2021-05-17
-$29.95M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$6.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$13.97M
derived: sum of 2 quarters · filed 2021-03-31
-$22.80M
derived: sum of 3 quarters · filed 2021-03-31
-$31.86M
10-K · filed 2021-03-31
2019-09-30-$7.64M
10-Q · filed 2020-11-13
-$16.47M
derived: sum of 2 quarters · filed 2020-11-13
-$25.54M
10-Q · filed 2020-11-13
2019-06-30-$8.83M
10-Q · filed 2020-08-14
-$17.89M
10-Q · filed 2020-08-14
2019-03-31-$9.07M
10-Q · filed 2020-05-14
2018-12-31-$29.52M
10-K · filed 2020-03-09